Termo Health Tecnologia

Termo Health Tecnologia is a Brazilian health tech company that developed the LINDA platform, an AI-powered diagnostic tool for the early detection of breast cancer using high-resolution thermography. The technology identifies thermal patterns associated with breast abnormalities, providing a non-invasive and radiation-free screening option that complements traditional mammography. Headquartered in São Paulo, the company has received regulatory authorization from ANVISA and is expanding its reach to improve cancer screening accessibility. Beyond its diagnostic device, Termo Health is also active in pharmaceutical research, focusing on the development of thiazole derivatives for oncology applications. The company aims to bridge the gap in early cancer detection through innovative technology and data-driven insights.